Trials / Sponsors / Rapa Therapeutics LLC
Rapa Therapeutics LLC
Industry · 6 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma Malignant Melanoma With Metastasis, Malignant Melanoma, Malignant Melanoma Stage IIIc | Phase 2 | 2027-03-01 |
| Recruiting | RAPA-501 Therapy for ALS Amyotrophic Lateral Sclerosis | Phase 2 / Phase 3 | 2025-01-02 |
| Recruiting | RAPA-201 Therapy of Solid Tumors Solid Tumor, Small Cell and Non-small Cell Lung Cancer, Head and Neck Cancer | Phase 1 / Phase 2 | 2021-08-01 |
| Terminated | RAPA-501-Allo Therapy of COVID-19-ARDS Severe COVID-19 Disease | Phase 1 / Phase 2 | 2020-12-30 |
| Completed | RAPA-201 T Cell Therapy for Relapsed, Refractory Multiple Myeloma Relapsed, Refractory Multiple Myeloma | Phase 2 | 2020-12-02 |
| Temporarily Not Available | RAPA-501 Therapy of ALS Expanded Access Protocol Amyotrophic Lateral Sclerosis | — | — |